Wound care gamechanger SolasCure wins £405k grant
SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound care, has won a £405k Biomedical Catalyst grant from Innovate UK. The money will support the continued clinical development of SolasCure’s first investigational product, Aurase Wound Gel.